| Code | Product Name | CAS Number | Purity/Assay |
|---|---|---|---|
| 1207 | L-Homoserine | 672-15-1 | 99% |
| D-Homoserine | 6027-21-0 | 99% | |
| (S)-2-Amino-γ-butyrolactone hydrochloride | 2185-03-7 | 98% | |
| (R)-2-Amino-γ-butyrolactone hydrochloride | 104347-13-9 | 98% | |
| (S)-3-Aminotetrahydrofuran hydrochloride | 204512-95-8 | 98% | |
| (R)-3-Aminotetrahydrofuran hydrochloride | 1072015-52-1 | 98% | |
| (S)-2-Amino-4-bromobutyric acid hydrochloride | 15159-65-6 | 98% | |
| (R)-2-Amino-4-bromobutyric acid hydrochloride | 177472-34-3 | 98% | |
| 4,6-Dimethylpyrimidinone | 108-79-2 | 98% | |
| Cotinine | 486-56-6 | 97% | |
| Dehydroepiandrosterone acetate (DHEA Acetate) | 853-23-6 | 98% | |
| 0545 | Eflornithine Hydrochloride (1) | 68278-23-9 | 98% |
| Pyridostigmine bromide | 101-26-8 | 99% | |
| Pyridoxamine dihydrochloride | 524-36-7 | 97% | |
| Salacinol | 200399-47-9 | 98% | |
| Thalidomide | 50-35-1 | 98% |
Patent
(1) Eflornithine Hydrochloride
US 6,998,502; US 7,345,196: Convenient process of manufacture for difluoromethylornithine and related compounds
† Disclaimer
This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.